N- and O-glycans • Defined terminal epitopes • Presentation-aware research panels

Mammalian Glycan Synthesis Services

BOC Sciences provides mammalian glycan synthesis support for antibody and glycoprotein glycoform research, receptor recognition, cell adhesion, and disease-associated glycosylation studies. Targets include high-mannose, hybrid, and complex N-glycans, mucin-type O-glycans, and defined sialylated or fucosylated structures. Each project specifies branch architecture, residue linkages, core modifications, and the presentation required for the intended experiment.

  • Family-level planning with residue- and arm-defined targets
  • Terminal and core modifications treated as separate variables
  • Free glycans, specified derivatives, and presentation-matched panels

Discuss Your Target Explore Synthesis Options

Four text cards distinguish high-mannose, hybrid, and complex N-glycans from mucin-type O-glycans.Mammalian glycan project families. Exact residue structures, branch positions, terminal linkages, and molecular presentation are specified separately; the cards are not molecular structures.

Project specification

Define the target and intended use
01 N- or O-glycan family and drawing
02 Arm composition and linkage map
03 Core and terminal modifications
04 Sialic-acid identity and linkage
05 Reducing end, label, or attachment
06 Amount and analytical evidence

Custom synthesis scope

Mammalian Glycan Synthesis Across N- and O-Glycan Families

A glycan composition can correspond to multiple branch or linkage isomers. We use a complete target structure to connect the chosen glycan family with the specific biological comparison. Human targets and other mammalian structures are distinguished where residue identity or modification differs.

01
N-glycan families

High-Mannose, Hybrid, and Complex N-Glycans

Discuss high-mannose structures such as specified Man5-Man9 targets, hybrid structures with different arm compositions, and complex structures with defined antennae. Mannose count or antenna number alone may not identify a unique glycan. Branch placement, terminal sugars, bisecting GlcNAc, and core fucosylation are included where relevant.

  • Branch and linkage isomers distinguished
  • Hybrid arms identified individually
  • Core modifications stated explicitly
02
Mucin-related targets

Mucin-Type O-Glycan Structures

Plan O-GalNAc structures with the required core, extension, terminal epitope, and attachment format. A free oligosaccharide, an alpha-GalNAc derivative, and an O-glycopeptide are different materials. If a peptide context is needed, specify the Ser/Thr site and sequence rather than assuming that a released O-glycan reproduces the native attachment.

  • Core and extension sequence
  • GalNAc attachment and configuration
  • Free glycan or glycopeptide scope
03
Epitope comparisons

Sialylated and Fucosylated Epitope Panels

Prepare targets differing in sialic-acid linkage, fucose placement, or terminal extension. Neu5Ac and Neu5Gc are specified separately; Neu5Gc is relevant to some nonhuman mammalian contexts and is not a routine human glycan residue. Core alpha1,6 fucose and antennary fucose describe distinct structural features.

  • Alpha2,3 and alpha2,6 sialylation specified
  • Core versus antennary fucosylation
  • Defined terminal and arm-specific occupancy
04
Assay formats

Presentation-Matched Glycan Derivatives

Discuss reducing-end handles, labels, and other derivatives for immobilization or conjugation. The linker, attachment chemistry, and delivered glycan form are identified in the specification. A free glycan or neoglycoconjugate does not recreate every effect of protein conformation, site occupancy, density, or neighboring glycans.

  • Label and linker identity
  • Attachment site and final derivative
  • Comparable presentation across panels
Mammalian glycan planning defines the N- or O-glycan core, arm architecture, core modifications, and terminal linkages before route and final-format assessment.

Target-specific route assessment

Select Assembly Routes Around Branches and Terminal Residues

Chemical, enzymatic, and combined routes offer different access to mammalian glycan structures. Target definition, enzyme substrate scope, branch selectivity, and the required reducing end guide route selection.

Define the Core and Each Arm

The synthesis map identifies the N-glycan core or O-glycan core before extension. Antenna composition is recorded by arm, including asymmetric structures and partial terminal modification. A composition code or total sialic-acid count is supplemented with a drawing when positional identity matters.

Review Extension and Remodeling Options

Transferase-based extension can access selected termini when suitable acceptors are available. Chemical assembly may be needed for unusual cores, modifications, or attachment formats. Published enzyme acceptance for one substrate does not establish activity on every branched or derivatized analog.

Protect Sensitive Features During Isolation

Sialylated and other labile structures require compatible reaction, purification, and storage conditions. The final label or linker may change separation behavior. Characterization is performed on the delivered material, with free and derivatized forms distinguished in the data record.

Discuss the Synthesis Route

Material and project decisions

Choose a Glycan Panel That Isolates the Research Variable

Useful comparisons preserve selected features while changing the structural variable under study. The following decisions should be made before synthesis rather than inferred from a family name.

Research variableStructural definitionUseful comparison
Mannose trimmingExact high-mannose branch structure at each residue countDefined Man5-Man9 members or selected branch isomers
Hybrid versus complex architectureComposition and extension of each armStructures with selected terminal features held constant
N-glycan core modificationBisecting GlcNAc, alpha1,6 core fucose, and all other residuesA matched pair with one declared core change
Terminal sialylationNeu5Ac/Neu5Gc identity, linkage, and modified armSpecified alpha2,3/alpha2,6 or occupancy series
Mucin-type O-glycan extensionCore sequence, terminal motif, and attachment formatCore or extension variants with comparable presentation
Protein-context effectsProtein, glycosylation site, occupancy, and neighboring structuresSeparate glycan and defined glycoconjugate experiments

Our Glycan Synthesis Services provide a broader entry point, while Glycan Conjugation Services support separately scoped attachment projects. Individual glycoform studies require agreement on both the glycan structure and its molecular context.

Structure-to-data consistency

Connect Composition with Branch and Linkage Evidence

Analytical requirements depend on whether the study needs family identity, an isolated isomer, or a fully assigned derivative. No single composition measurement answers all three questions.

Explore Glycan Separation

Composition

Expected Residues and Final Mass

Mass analysis supports the proposed glycan composition and final derivative. It does not independently locate a fucose, identify a modified arm, or distinguish every isomer. Salt forms, reducing-end chemistry, and labels are considered during interpretation.

Connectivity

Branch and Linkage Assignment

Suitable NMR, fragmentation, and selective enzymatic evidence can contribute to the assignment. The agreed package states which arms, terminal linkages, and core modifications need confirmation. A biosynthetic label alone is not sufficient evidence for a unique asymmetric structure.

Separation

Isomers and Incomplete Extension

Chromatography is selected to assess relevant precursors, partially extended species, and plausible isomers. Peak area and structural confidence are reported separately. Where a reference or resolving method is unavailable, that limitation remains explicit in the analytical record.

Presentation

Delivered Derivative and Attachment

For functionalized glycans, confirm the linker or label and the intended attachment state. Conjugation metrics and protein-site occupancy belong to a separately agreed glycoconjugate package. Free-glycan purity does not establish a homogeneous glycoprotein glycoform.

Research applications

Mammalian Glycans for Glycoform and Recognition Research

Defined synthetic structures help separate glycan variables that are difficult to resolve in heterogeneous biological samples. Results remain dependent on presentation and the experimental system.

Antibody and Glycoprotein Glycoform Research

Use structurally defined glycans as references or as inputs to a separately designed remodeling or conjugation project. Changes in a free glycan cannot by themselves predict antibody effector function or protein behavior. Protein identity, site occupancy, and attached glycoform distribution require their own evidence.

Receptor and Lectin Recognition

Compare branch architecture, core modifications, or terminal epitopes using a controlled panel. Ligand density, immobilization orientation, and multivalent display can alter apparent recognition. Matched derivatives help distinguish the selected structural variable from avoidable presentation differences.

Cell-Adhesion and Disease-Associated Glycosylation Studies

Investigate specified epitopes in adhesion or disease-related research models without treating a glycan motif as disease-specific. Sialylation and fucosylation occur in many biological contexts. Suitable controls and the chosen cell or receptor model determine what an observed response can support.

A defined synthesis project

Plan a Mammalian Glycan Panel from Structure to Assay Format

The project starts with the glycan variable and the form in which it will be studied, then aligns assembly, separation, and structural evidence.

Project brief

Send the structure and project requirements

Send the complete glycan drawings, species context, arm-specific modifications, reducing end, intended assay format, desired amount, and any paired glycoform references.

Start an Inquiry

1 Resolve Family and Exact Structure

Confirm N- or O-glycan type, all linkages, core features, and terminal residue identities. Expand ambiguous composition codes into drawings.

2 Define the Comparative Panel

Choose branch, core, or terminal variants and record the features held constant. Distinguish glycan-only comparisons from protein-context experiments.

3 Assess Assembly and Presentation

Review chemical or enzyme-mediated access alongside label, linker, or glycopeptide requirements. Scope attached glycoprotein work separately where needed.

4 Prepare and Characterize Targets

Isolate the agreed structures and collect composition, connectivity, and separation evidence appropriate to the requested resolution.

5 Deliver the Material and Structural Record

Provide individual identities, analytical records, and handling information. Keep optional recognition measurements linked to their actual assay conditions.

Project advantages

Advantages of a Structure- and Presentation-Defined Project

BOC Sciences coordinates family-level synthesis planning with the details that determine whether a mammalian glycan panel can answer the intended research question.

Arm-Resolved Specifications

The project goes beyond total residue counts to identify branch architecture and positions of terminal or core modifications.

Appropriate Molecular Context

Free glycans, labeled derivatives, glycopeptides, and protein-attached glycoforms are distinguished before defining deliverables.

Useful Comparison Sets

Reference structures and analytical requirements are selected around the variable being investigated, with sensitive terminal residues considered during processing.

One connected glycan platform

Connect Mammalian Glycan Synthesis with Related Services

Related insights

Resources for Mammalian Glycan Synthesis

Explore supporting information on synthesis, characterization, and material selection for your project.

Structural Isomerism in Glycans: Analytical Challenges and Resolution StrategiesAnalytical Techniques for Glycan CharacterizationApplications of Synthetic Glycans in Biopharma Research

Frequently asked questions

Mammalian Glycan Synthesis FAQ

Answers to common questions about the requested structures, characterization, and project scope.

Which mammalian glycan families can be discussed?

Targets include high-mannose, hybrid, and complex N-glycans, mucin-type O-glycans, and specified sialylated or fucosylated structures. Feasibility depends on the exact drawing, final derivative, quantity, and required structural resolution.

References

  1. Li L et al. Efficient Chemoenzymatic Synthesis of an N-glycan Isomer Library. Chemical science, 2015, 6(10):5652-5661. DOI: 10.1039/c5sc02025e.
  2. Wang S et al. Chemoenzymatic modular assembly of O-GalNAc glycans for functional glycomics. Nature communications, 2021, 12(1):3573. DOI: 10.1038/s41467-021-23428-x.
  3. Toonstra C et al. Top-Down Chemoenzymatic Approach to Synthesizing Diverse High-Mannose N-Glycans and Related Neoglycoproteins for Carbohydrate Microarray Analysis. Bioconjugate chemistry, 2018, 29(6):1911-1921. DOI: 10.1021/acs.bioconjchem.8b00145.

Define the research material your project needs

Discuss a Mammalian Glycan Synthesis Panel

Share your N- or O-glycan targets with BOC Sciences, including each arm, core modification, terminal epitope, and intended presentation. Add the research comparison, desired amounts, and analytical requirements. We can assess a synthesis plan for defined materials that support your glycoform, recognition, or cell-adhesion study.

Contact BOC Sciences to discuss target-specific feasibility, specifications, and the required analytical package. Materials are intended for research use.

Request a Custom Quote
* Only for research. Not suitable for any diagnostic or therapeutic use.
Send Inquiry
Verification code